IL1B and silicosis: IL-1RA is an inhibitor of pro-inflammatory IL-1 and has been proposed as a good biomarker candidate for disease progression due to the increase in its levels as silicosis stages progress, which could be indicative of a mechanism to balance the effect of IL-1β [25,70].